|
Macular Disorders
Citations 1-10 of 123 total displayed.
|
Most recent content
(1 Sep 2009):
|
- Clinical Trials
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5
- The SCORE Study Research Group
Arch Ophthalmol 2009; 127: 1101-1114.
[Abstract]
[Full text]
[PDF]
[ eTable ]
- Clinical Trials
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 6
- The SCORE Study Research Group
Arch Ophthalmol 2009; 127: 1115-1128.
[Abstract]
[Full text]
[PDF]
- Epidemiology
The Relation of Markers of Inflammation and Endothelial Dysfunction to the Prevalence and Progression of Diabetic Retinopathy: Wisconsin Epidemiologic Study of Diabetic Retinopathy
- Barbara E. K. Klein; Michael D. Knudtson; Michael Y. Tsai; Ronald Klein
Arch Ophthalmol 2009; 127: 1175-1182.
[Abstract]
[Full text]
[PDF]
- Editorials
SCOREing in Retinal Venous Occlusive Disease
- Rajendra S. Apte
Arch Ophthalmol 2009; 127: 1203-1204.
[Extract]
[Full text]
[PDF]
|
Past content
(since Aug 1998):
|
- Ophthalmic Molecular Genetics
Phenotypic Variability Due to a Novel Glu292Lys Variation in Exon 8 of the BEST1 Gene Causing Best Macular Dystrophy
- Elliott H. Sohn; Peter J. Francis; Jacque L. Duncan; Richard G. Weleber; David A. Saperstein; Donald F. Farrell; Edwin M. Stone
Arch Ophthalmol 2009; 127: 913-920.
[Abstract]
[Full text]
[PDF]
- Letters
Potential Causes of Altered Autofluorescence in Diabetic Persons
- Richard F. Spaide
Arch Ophthalmol 2009; 127: 942-943.
[Extract]
[Full text]
[PDF]
- Letters
Potential Causes of Altered Autofluorescence in Diabetic Persons—Reply
- Matthew G. Field; Victor M. Elner; Jason M. Feuerman; John R. Heckenlively; Howard R. Petty
Arch Ophthalmol 2009; 127: 943-945.
[Extract]
[Full text]
[PDF]
- Clinical Trials
Pegaptanib Sodium for Macular Edema Secondary to Central Retinal Vein Occlusion
- John J. Wroblewski; John A. Wells III; Anthony P. Adamis; Ronald R. Buggage; Emmett T. Cunningham Jr; Mauro Goldbaum; David R. Guyer; Barrett Katz; Michael M. Altaweel; for the Pegaptanib in Central Retinal Vein Occlusion Study Group
Arch Ophthalmol 2009; 127: 374-380.
[Abstract]
[Full text]
[PDF]
- Clinical Sciences
Management of Autoimmune Retinopathies With Immunosuppression
- Henry A. Ferreyra; Thiran Jayasundera; Naheed W. Khan; Shirley He; Ying Lu; John R. Heckenlively
Arch Ophthalmol 2009; 127: 390-397.
[Abstract]
[Full text]
[PDF]
- Editorials
Immunosuppression for Autoimmune Retinopathy
- Lee M. Jampol; Gerald A. Fishman
Arch Ophthalmol 2009; 127: 573-575.
[Extract]
[Full text]
[PDF]
|
|
